View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/SAMHSA RIN: 0930-AA22 Publication ID: Spring 2016 
Title: Increase Number of Patients to Which Drug Addiction Treatment Act (DATA)-Waived Physicians Can Prescribe Buprenorphine 
Abstract:

Under the Drug Addiction Treatment Act of 2000, physicians must qualify and apply for a waiver to prescribe buprenorphine for opioid dependency.  After one year, physicians can apply to SAMHSA to increase the buprenorphine treatment from 30 patients to 100 patients.  The purpose of this rule is to expand access to medication-assisted treatment (MAT) by increasing the total number of patients a practitioner may treat with buprenorphine.  The rule also includes requirements to ensure that patients receive the full array of services that compromise evidence-based MAT and minimize the risk that the medications provided for treatment are misused or diverted. 

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 42 CFR 8   
Legal Authority: 21 U.S.C. 823(g)(2)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  03/30/2016  81 FR 17639   
NPRM Comment Period End  05/31/2016 
Final Action  09/00/1016 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Federal, Local, State, Tribal 
Federalism: No 
Included in the Regulatory Plan: Yes 
RIN Data Printed in the FR: No 
Agency Contact:
Brian Altman
Legislative Director
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road,
Rockville, MD 02857
Phone:240 276-2009
Email: brian.altman@samhsa.gov